Diabetes self-management education (DSME) has a lasting, positive effect on glycemic control in patients with diabetes, especially among those whose duration of diabetes is less than 1 year, according to study results published in Diabetes Spectrum.
Researchers gauged the glycemic control of 43 patients using HbA1c over a 2-year period after patients received DSME. The patients completed DSME in 2009, and HbA1c measurements were recorded prior to DSME, immediately after, 1 year after and 2 years after. The analysis included 43 patients.
The average HbA1c of the patients dropped from 10.2% to 7.8% (mean decrease, 23.5%) immediately after they received DSME. Even after 1 and 2 years passed since receiving DSME, the average HbA1c of the patients remained at 7.8%, showing that DSME has lasting effects on glycemic control.
Even though all patients experienced a significant improvement in glycemic control after DSME, the duration of patients’ diabetes prior to receiving the DSME affected their average post-DSME HbA1c. Patients who had diabetes for less than 1 year experienced a significantly greater reduction in HbA1c after DSME, with an average decrease of 28.7%. Patients who had diabetes for longer than 1 year only saw an average decrease of 20.2% in their post-DSME HbA1c.
Diabetes Self-Management Education Improves Glycemic Control
Researchers recently conducted a study to determine whether diabetes self-management education could have lasting benefits on glycemic control. Results are published here in Diabetes Spectrum.
Enjoying our content?
Thanks for visiting Endocrinology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Endocrinology Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.